| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.
|
N Engl J Med
|
2000
|
18.04
|
|
2
|
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.
|
JAMA
|
2001
|
15.85
|
|
3
|
Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.
|
Circulation
|
2000
|
8.17
|
|
4
|
Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events.
|
N Engl J Med
|
2001
|
7.51
|
|
5
|
Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women.
|
Am J Clin Nutr
|
2002
|
3.00
|
|
6
|
Soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule-1, and the development of symptomatic peripheral arterial disease in men.
|
Circulation
|
2002
|
2.84
|
|
7
|
Blood pressure and inflammation in apparently healthy men.
|
Hypertension
|
2001
|
2.55
|
|
8
|
Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke.
|
Circulation
|
1999
|
2.36
|
|
9
|
Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women.
|
Circulation
|
2002
|
2.36
|
|
10
|
Clinical efficacy of an automated high-sensitivity C-reactive protein assay.
|
Clin Chem
|
1999
|
2.35
|
|
11
|
Hormone replacement therapy and increased plasma concentration of C-reactive protein.
|
Circulation
|
1999
|
1.96
|
|
12
|
Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, and cytomegalovirus and the risk for cardiovascular disease in women.
|
Ann Intern Med
|
1999
|
1.91
|
|
13
|
Lack of association of C-reactive protein and coronary calcium by electron beam computed tomography in postmenopausal women: implications for coronary artery disease screening.
|
J Am Coll Cardiol
|
2000
|
1.62
|
|
14
|
C-reactive protein gene polymorphisms and the risk of venous thromboembolism: a haplotype-based analysis.
|
J Thromb Haemost
|
2004
|
1.46
|
|
15
|
A prospective evaluation of the interleukin-1 receptor antagonist intron 2 gene polymorphism and the risk of myocardial infarction.
|
Thromb Haemost
|
2001
|
1.45
|
|
16
|
Mutation in the promoter region of the beta-fibrinogen gene and the risk of future myocardial infarction, stroke and venous thrombosis.
|
Eur Heart J
|
2001
|
1.44
|
|
17
|
Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis.
|
Atherosclerosis
|
2002
|
1.42
|
|
18
|
A prospective evaluation of lipoprotein-associated phospholipase A(2) levels and the risk of future cardiovascular events in women.
|
J Am Coll Cardiol
|
2001
|
1.38
|
|
19
|
A prospective evaluation of the CD14 C(-260)T gene polymorphism and the risk of myocardial infarction.
|
Atherosclerosis
|
2001
|
1.03
|
|
20
|
A prospective study of Helicobacter pylori seropositivity and the risk for future myocardial infarction among socioeconomically similar U.S. men.
|
Ann Intern Med
|
2001
|
0.98
|
|
21
|
Plasma levels of cystatin-C and mannose binding protein are not associated with risk of developing systemic atherosclerosis.
|
Vasc Med
|
2001
|
0.82
|
|
22
|
A prospective evaluation of the CD14 and CD18 gene polymorphisms and risk of stroke.
|
Stroke
|
2002
|
0.79
|
|
23
|
High sensitivity C-reactive protein for predicting cardiovascular disease: an inflammatory hypothesis.
|
Eur Heart J
|
2001
|
0.79
|
|
24
|
A prospective evaluation of the heat shock protein 70 gene polymorphisms and the risk of stroke.
|
Thromb Haemost
|
2002
|
0.75
|